about
A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients.What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial.Costs of a community pharmacist-led medicines management service for patients with coronary heart disease in England: healthcare system and patient perspectives.Patient evaluation of a community pharmacy medications management service.What, who and when? Incorporating a discrete choice experiment into an economic evaluation.Survey of patients' experiences and perceptions of care provided by nurse and pharmacist independent prescribers in primary care.Do cancer-specific websites meet patient's information needs?Improving hospital discharge arrangements for people who are homeless: A realist synthesis of the intermediate care literature.Decision-making criteria among European patients: exploring patient preferences for primary care services.Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland.Outcomes of specialist discharge coordination and intermediate care schemes for patients who are homeless: analysis protocol for a population-based historical cohort.Implementing shared-decision-making for diabetes care across country settings: What really matters to people?The authors' reply to Koeser and McCrone: "on the use and interpretation of quantile regression in quality-of-life research".Using IMPrESS to guide policy change in multiple sclerosis.Patients' valuation of the prescribing nurse in primary care: a discrete choice experiment.Valuing the Extended Role of Prescribing Pharmacist in General Practice: Results from a Discrete Choice ExperimentDevelopment, validation and application of a patient satisfaction scale for a community pharmacy medicines-management serviceNovel pharmacist-led intervention secures the minimally important difference (MID) in Asthma Control Test (ACT) score: better outcomes for patients and the healthcare providerValue of schizophrenia treatment II: Decision modelling for developing early detection and early intervention services in the Czech RepublicTime matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?Value of treatment of headache patients and need to improve headache patients’ journeyImproving quality care for diabetes in the community: What do Cypriot patients want?Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responsesPatients' preferences for an increased pharmacist role in the management of drug therapyValue assessment of disease-modifying therapies for Relapsing-Remitting Multiple Sclerosis: HTA evidence from seven OECD countries
P50
Q33602083-AA479176-FFA6-4609-94D7-AAE045C1921DQ34433465-E169F2C5-5425-4CC6-9B98-4B2BFC7EDBFEQ36815062-B0DC0072-9D02-4CD6-9F8A-C0A885B079D0Q36986272-C50793B5-49F1-4BDC-A301-C58F3946B35DQ37139254-AA368F67-4268-491E-AB08-76A350698AFDQ37333392-C8C58804-121E-4F0D-B03E-6AABA48CF6A3Q38180524-1AA4BF81-DFF9-4F44-B571-F99E4EDB1BD6Q39449929-4B803FDE-9BCA-4D20-A7DE-75F1D760ACA3Q39525486-528359B6-5E14-4A9F-93FF-1D98EA55E9F3Q40156431-092817B4-C124-4AF6-8277-7159BF7DFD9BQ47097762-4AFCDEB0-C722-437C-B2E6-CAFFAB519507Q47864850-5B084FF7-5A69-442A-A406-318E9FC387C6Q48094344-BFEAD207-C487-4C0F-9C2B-0523B507BD2CQ48568452-1A144063-6353-4C3A-B2C3-EB4A2CF7EDE9Q49624399-2D3E382F-791E-484E-A5DD-F5EA38BFDB92Q57393597-DE50A5B5-C48D-4A75-9334-227FC8295850Q57393598-2D09D6E8-1BC1-4947-81F2-48BF2FB8793FQ58567196-E54D763C-0072-490E-901F-8597FA25E92DQ60642710-FA0A0EDE-A1C7-4A5B-906E-BCAAED843FDEQ60686207-FE0E0996-AE13-427E-8232-9BDE526312B5Q60698165-AE201CBB-7A87-46ED-8E50-167C127705E4Q62384033-6FCA6DDB-7C7C-4D8B-A007-C7DA09E382B6Q62384037-05EE8675-1754-46D8-B76A-1C27FFA23E36Q62384038-0D42FBC5-2590-4E15-9983-3342FA9DBA1EQ91515924-0B388BE1-6FB6-481F-B77E-1F43D9E0043C
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michela Tinelli
@ast
Michela Tinelli
@en
Michela Tinelli
@es
Michela Tinelli
@nl
Michela Tinelli
@sl
type
label
Michela Tinelli
@ast
Michela Tinelli
@en
Michela Tinelli
@es
Michela Tinelli
@nl
Michela Tinelli
@sl
prefLabel
Michela Tinelli
@ast
Michela Tinelli
@en
Michela Tinelli
@es
Michela Tinelli
@nl
Michela Tinelli
@sl
P106
P21
P31
P496
0000-0002-8816-4389
P569
2000-01-01T00:00:00Z